ImmunityBio
IBRX
IBRX
208 hedge funds and large institutions have $239M invested in ImmunityBio in 2025 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 74 increasing their positions, 41 reducing their positions, and 32 closing their positions.
Holders
208
Holders Change
+8
Holders Change %
+4%
% of All Funds
2.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
45
Increased
74
Reduced
41
Closed
32
Calls
$7.5M
Puts
$13.2M
Net Calls
-$5.68M
Net Calls Change
-$4.04M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$61.2M |
2 |
2
Citigroup
New York
|
$8.17M |
3 |
![]()
3
Group One Trading
Chicago,
Illinois
|
$4.05M |
4 |
4
Verition Fund Management
Greenwich,
Connecticut
|
$2.49M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$12.9M |